Dissemin is shutting down on January 1st, 2025

Published in

Current Protocols in Immunology, p. 15.25.1-15.25.14

DOI: 10.1002/0471142735.im1525s104

Links

Tools

Export citation

Search in Google Scholar

Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice

Journal article published in 2014 by Benoit Chassaing ORCID, Jesse D. Aitken, Madhu Malleshappa, Matam Vijay-Kumar
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Inflammatory bowel diseases (IBD), mainly comprising ulcerative colitis and Crohn's Disease, are complex and multifactorial diseases with unknown etiology. For the past 20 years, to study human IBD mechanistically, a number of murine models of colitis have been developed. These models are indispensable tools to decipher underlying mechanisms of IBD pathogenesis as well as to evaluate a number of potential therapeutics. Among various chemically induced colitis models, the dextran sulfate sodium (DSS)-induced colitis model is widely used because of its simplicity and many similarities with human ulcerative colitis. This model has both advantages and disadvantages that must be considered when employed. This protocol describes the DSS-induced colitis model, focusing on details and factors that could affect DSS-induced pathology. Curr. Protoc. Immunol. 104:15.25.1-15.25.14. © 2014 by John Wiley & Sons, Inc.